ACN
50
-6
FOX
50
-14
HUM
43
-5
PYPL
56
13
PH
71
-2
EQT
39
-5
WAT
61
2
PVH
70
6
WYNN
33
-9
PGR
63
-4
CMG
64
-5
HIG
68
-7
MTB
63
-2
MET
67
-5
JNJ
45
-2
EFX
41
-3
AEP
53
-5
RRC
52
-6
DE
63
-2
SJM
33
14
ACN
50
-6
FOX
50
-14
HUM
43
-5
PYPL
56
13
PH
71
-2
EQT
39
-5
WAT
61
2
PVH
70
6
WYNN
33
-9
PGR
63
-4
CMG
64
-5
HIG
68
-7
MTB
63
-2
MET
67
-5
JNJ
45
-2
EFX
41
-3
AEP
53
-5
RRC
52
-6
DE
63
-2
SJM
33
14
Financhill
Back

Dianthus Therapeutics Stock Predictions

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

DNTH
Dianthus Therapeutics

Last Price:
25.33
Seasonality Move:
19.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Dianthus Therapeutics Stock Forecast

  • Over the next 52 weeks, Dianthus Therapeutics has on average historically fallen by 5.6% based on the past 6 years of stock performance.
  • Dianthus Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Dianthus Therapeutics Stock Undervalued?
    The current Dianthus Therapeutics [DNTH] share price is $25.70. The Score for DNTH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • DNTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Dianthus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dianthus Therapeutics has on average historically fallen by 5.6% based on the past 6 years of stock performance.

Dianthus Therapeutics Stock Rating

Sell
37
Dianthus Therapeutics (DNTH) is a Sell

Is Dianthus Therapeutics overpriced?

  • Dianthus Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Dianthus Therapeutics Stock Price History

Is DNTH stock going to rise?

  • The current trend is relatively stagnant and DNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dianthustx.com

52-Week Data

52-Week High:
33.77
52-Week Low:
6.58

Prediction Charts

Market Cap:
760.64M
Price in USD:
25.70
Volume:
309.38K
Beta:
2.03

Technical Analysis

SMA50:
26.70
SMA100:
27.34
SMA200:
26.19
52-Wk Change:
128.04%

Stock Predictions

  • Is Dianthus Therapeutics stock public?
    Yes, Dianthus Therapeutics is a publicly traded company.
  • What is the Dianthus Therapeutics stock quote today?
    The Dianthus Therapeutics stock price is 25.70 USD today.
  • How to buy Dianthus Therapeutics stock online?
    You can buy Dianthus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-12 27.41 27.68 28.01 26.07
Nov-13 28.14 26.35 28.56 25.69
Nov-14 26.49 25.49 27.56 25.35
Nov-15 25.55 23.36 25.93 22.19
Nov-18 23.11 23.60 24.10 22.88
Nov-19 23.09 22.27 23.62 21.92
Nov-20 22.09 20.77 22.45 20.53
Nov-21 20.88 20.27 20.98 19.85
Nov-22 20.37 22.34 22.39 20.37
Nov-25 22.85 23.45 24.30 22.85
Nov-26 23.24 23.86 24.24 22.89
Nov-27 23.81 23.83 23.99 23.07
Nov-29 23.80 23.99 24.28 22.88
Dec-2 24.02 25.70 25.89 23.62

Dianthus Therapeutics Earnings

Dianthus Therapeutics Earnings Report: Per Share Dianthus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dianthus Therapeutics Forecast Revenue Growth

Dianthus Therapeutics Stock Analysis: Historical quarterly revenues per share for Dianthus Therapeutics and historical quarterly revenue growth:

* Dianthus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.